Is Elevance Health Inc. overvalued?

Elevance Health Inc. (ELV) looks overvalued — trading about 11% above its fair value.

Overvalued

Price

$429.69

Fair value

$384.56

Current P/E

17.1

Normal P/E

15.3

Market cap

$92.84B

Dividend yield

1.6%

Return on equity

11.6%

Sector

Healthcare

Fair value compares ELV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks